as on November 25, 2025 at 4:01 pm IST
Day's Low
Day's High
1.41%
Downside
4.17%
Upside
52 Week's Low
52 Week's High
64.25%
Downside
10.99%
Upside
as on November 25, 2025 at 4:01 pm IST
Market Cap
₹865.95 Cr
Return on Equity (ROE)
14.34
PE Ratio (TTM)
24.48
Return on capital employed (ROCE)
16.95
Industry PE ratio
41.99
Beta (LTM)
0.66
P/B Ratio
2.81
Dividend Yield
0PEG Ratio
0.32
Quarterly Earnings Growth YOY
943
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
as on November 25, 2025 at 4:01 pm IST
Fredun Pharmaceuticals Ltd in the last 5 years
Lowest (0.00x)
March 28, 2025
Today (24.48x)
November 21, 2025
Industry (41.99x)
November 21, 2025
Highest (25.56x)
November 20, 2025
Today’s Price to Earnings Ratio: 24.48x
Compare market cap, revenue, PE, and other key metrics of Fredun Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 865.95 | 114.7% | 0.00 | 15 | 348 | |
| NA | 6.24 | -0.19% | 0.00 | -2 | 13 | |
| NA | 355.82 | -3.61% | 0.66 | 12 | 379 | |
| NA | 1,628.32 | 17.95% | 0.53 | 60 | 759 | |
| NA | 316.43 | -4.49% | 0.69 | -114 | 1,669 |
Search interest for Fredun Pharmaceuticals Ltd Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Fredun Pharmaceuticals Ltd.
Fredun Pharmaceuticals Ltd’s net profit jumped 18.58% since last year same period to ₹6.00Cr in the Q4 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated -56.33% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 per share on 31 May 2025 - translating a dividend yield of 0.04%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, Fredun Pharma stock has moved up by 44.8%
Best in 1 Year
![]()
In the last 1 year, Fredun Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.00% to 0.01% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 48.93% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.2% return, outperforming this stock by 77.8%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 49.48% to 49.45% in Sep 2025 quarter
| Organisation | Fredun Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Daulat N Medhora |
| E-voting on shares | Click here to vote |
Fredun Pharmaceuticals Ltd share price today stands at ₹1776 as on at the close of the market. Fredun Pharmaceuticals Ltd share today touched a day high of ₹1850 and a low of ₹1751.
Fredun Pharmaceuticals Ltd touched a 52 week high of ₹1971.25 and a 52 week low of ₹635. Fredun Pharmaceuticals Ltd share price today i.e. is closed at ₹1776, which is -9.90% down from its 52 week high and 179.69% up from its 52 week low.
Fredun Pharmaceuticals Ltd market capitalisation is ₹865.95 Cr as on .
To buy Fredun Pharmaceuticals Ltd shares, you need to follow these steps:
Fredun Pharmaceuticals Ltd trading volume is 5,734.00 as on . This means that 5,734.00 shares of Fredun Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.